A role for the RNA pol II-associated PAF complex in AID-induced immune diversification

Antibody diversification requires the DNA deaminase AID to induce DNA instability at immunoglobulin (Ig) loci upon B cell stimulation. For efficient cytosine deamination, AID requires single-stranded DNA and needs to gain access to Ig loci, with RNA pol II transcription possibly providing both aspec...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of experimental medicine Vol. 209; no. 11; pp. 2099 - 2111
Main Authors Willmann, Katharina L, Milosevic, Sara, Pauklin, Siim, Schmitz, Kerstin-Maike, Rangam, Gopinath, Simon, Maria T, Maslen, Sarah, Skehel, Mark, Robert, Isabelle, Heyer, Vincent, Schiavo, Ebe, Reina-San-Martin, Bernardo, Petersen-Mahrt, Svend K
Format Journal Article
LanguageEnglish
Published United States The Rockefeller University Press 22.10.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Antibody diversification requires the DNA deaminase AID to induce DNA instability at immunoglobulin (Ig) loci upon B cell stimulation. For efficient cytosine deamination, AID requires single-stranded DNA and needs to gain access to Ig loci, with RNA pol II transcription possibly providing both aspects. To understand these mechanisms, we isolated and characterized endogenous AID-containing protein complexes from the chromatin of diversifying B cells. The majority of proteins associated with AID belonged to RNA polymerase II elongation and chromatin modification complexes. Besides the two core polymerase subunits, members of the PAF complex, SUPT5H, SUPT6H, and FACT complex associated with AID. We show that AID associates with RNA polymerase-associated factor 1 (PAF1) through its N-terminal domain, that depletion of PAF complex members inhibits AID-induced immune diversification, and that the PAF complex can serve as a binding platform for AID on chromatin. A model is emerging of how RNA polymerase II elongation and pausing induce and resolve AID lesions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
K.L. Willmann, S. Milosevic, and S. Pauklin contributed equally to this paper.
S. Pauklin's present address is Laboratory For Regenerative Medicine, University of Cambridge, Cambridge CB2 0SZ, England, UK.
ISSN:0022-1007
1540-9538
DOI:10.1084/jem.20112145